Market share of orphan drugs valued <$6,000 per year in 2017, by therapy class

This statistic depicts the market share of U.S. orphan drugs that cost patients less than $6,000 per year in 2017, by therapy class. In that year, drugs for central nervous system disorders an annual cost of under six thousand dollars per patient accounted for 4.2 percent of the total orphan drug market.

Market share of orphan drugs that cost patients less than $6,000 per year in 2017, by therapy class

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

October 2018

Region

United States

Survey time period

2017

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Orphan drugs"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.